Patents/Assignees

INXMED (NANJING) CO., Ltd.

8 patents in portfolio

US12257251utility2025
Use of FAK Inhibitor in Preparation of Drug for Treating Tumors Having NRAS Mutation
0 cites
US12121519utility2024
Use of BI853520 in Cancer Treatment
0 cites
US12115160utility2024
Combined Use of IN10018 and PLD
0 cites
US12097200utility2024
Combination of BI853520 with Chemotherapeutic Drugs
0 cites
US12064431utility2024
Use of BI853520 in Cancer Treatment
0 cites
US12059421utility2024
Use of BI853520 in Cancer Treatment
0 cites
US11999719utility2024
Solid Form of Compound
0 cites
US11986477utility2024
Drug Combination and Use for Treating Tumors
0 cites